These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28492204)

  • 1. Impact assessment study after 27 years of community-directed treatment with ivermectin in Galadimawa, Kaduna State, Nigeria.
    Babalola OE; Bassi A
    Niger Postgrad Med J; 2017; 24(1):14-19. PubMed ID: 28492204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis.
    Abiose A; Murdoch I; Babalola O; Cousens S; Liman I; Onyema J; Evans J; Gregory W; Jones B
    Br J Ophthalmol; 1994 Jan; 78(1):8-13. PubMed ID: 8110711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
    Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
    Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintaining compliance to ivermectin in communities in two West African countries.
    Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
    Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
    Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
    BMC Public Health; 2020 Aug; 20(1):1233. PubMed ID: 32787813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
    Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
    Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
    Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD
    Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The problem of trachoma within an onchocerciasis-endemic zone in Kaduna: need for a multilateral approach?
    Babalola OE; Abiose A; Barrie JR
    Ophthalmic Epidemiol; 2005 Oct; 12(5):311-9. PubMed ID: 16272051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.
    Greter H; Mmbando B; Makunde W; Mnacho M; Matuja W; Kakorozya A; Suykerbuyk P; Colebunders R
    BMJ Open; 2018 Mar; 8(3):e017188. PubMed ID: 29605818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
    Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
    Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
    Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
    Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
    Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
    BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
    Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
    Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerciasis as a risk factor for night blindness.
    Babalola OE
    Ophthalmic Epidemiol; 2012 Aug; 19(4):204-10. PubMed ID: 22775275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin.
    Ekpo UF; Eneanya OA; Nwankwo EN; Soneye IY; Weil GJ; Fischer PU; Nwaorgu OC
    BMC Infect Dis; 2022 Nov; 22(1):832. PubMed ID: 36357828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Household coverage of ivermectin distribution in birnin kudu local government area of Jigawa State, Nigeria.
    Raji LA; Babalola OE; Musa D; Hassan A; Raji I; Umar MM; Ogungbenjo JA; Alhassan MB
    Ann Afr Med; 2023; 22(3):252-258. PubMed ID: 37417010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual impairment and incidence of blindness in Liberia and their relation to onchocerciasis.
    Frentzel-Beyme RR
    Tropenmed Parasitol; 1975 Dec; 26(4):469-88. PubMed ID: 1216334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-directed treatment of onchocerciasis with ivermectin in Takum, Nigeria.
    Akogun OB; Audu Z; Weiss MG; Adelakun AO; Akoh JI; Akogun MK; Remme H; Kale OO
    Trop Med Int Health; 2001 Mar; 6(3):232-43. PubMed ID: 11299041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.